作者
Nedime Serakinci, W Nicol Keith
发表日期
2006/6/1
来源
European journal of cancer
卷号
42
期号
9
页码范围
1243-1246
出版商
Pergamon
简介
The aim of cell-based therapies is to replace or repair damaged tissues and organs. A diverse number of disorders are amenable to this approach, including haematopoietic, neurological and cardiovascular diseases, as well as bone defects and diabetes. Central to the success of cell therapy is the necessity to be able to identify, select, expand and manipulate cells outside the body. Recent advances in adult stem cell technologies and basic biology have accelerated therapeutic opportunities aimed at eventual clinical applications. Adult stem cells with the ability to differentiate down multiple lineages are an attractive alternative to human embryonic stem cells (hES) in regenerative medicine. In many countries, present legislation surrounding hES cells makes their use problematic, and indeed the origin of hES cells may represent a controversial issue for many communities. However, adult stem cells are not subject …
引用总数
2006200720082009201020112012201320142015201620172018201920202021202220236121594846685335343
学术搜索中的文章